Prevention by 5-HT1A receptor agonists of restraint stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Neuropharmacology

• Publication date

  1999-04-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1016/S0028-3908(98)00209-3PMID 10221756
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment

  2004cited by this paper
• Inhibition by 5-HT3 receptor antagonists of release of cholecystokinin-like immunoreactivity from the frontal cortex of freely moving rats

  2004cited by this paper
• The effect of central and systemic injection of the 5-HT1A receptor agonist 8-OHDPAT and the 5-HT1A receptor antagonist WAY100635 on periaqueductal grey-induced defence behaviour

  1997cited by this paper
• Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks

  1997cited by this paper
• Stress‐ and Yohimbine‐Induced Release of Cholecystokinin in the Frontal Cortex of the Freely Moving Rat: Prevention by Diazepam but Not Ondansetron

  1996cited by this paper
• Cholecystokinin in anxiety.

  1996cited by this paper
• 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

  1995cited by this paper
• Evidence for the involvement of the 5-HT1A receptor in CCK induced satiety in rats

  1995cited by this paper
• Anxiolytic effect of the 5-HT1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action.

  1995cited by this paper
• Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?

  1995cited by this paper
• 5-HT1A receptor agonists: recent developments and controversial issues.

  1995cited by this paper
• Heterogeneity of CCK-B receptors involved in animal models of anxiety.

  1994cited by this paper
• Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients

  1994cited by this paper
• The role of postsynaptic 5-HT1A receptors in the anticonflict effect of ipsapirone.

  1994cited by this paper
• Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze.

  1994cited by this paper
• Effects of 5-HT1A receptor ligands on a safety signal withdrawal procedure of conflict in the rat.

  1994cited by this paper
• The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder.

  1994cited by this paper
• Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat.

  1994cited by this paper
• 5-HT 1A receptors and changes in extracellular 5-HT in the guinea-pig prefrontal cortex: involvement in aversive behaviour

  1993cited by this paper
• Sustained 5-hydroxytryptamine release-inhibitory and anxiolytic-like action of the partial 5-HT1A receptor agonist, buspirone, after prolonged chronic administration.

  1993cited by this paper
• (−)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain

  1993cited by this paper
• Release of Cholecystokinin‐Like Immunoreactivity in the Frontal Cortex of Conscious Rats as Assessed by Transcerebral Microdialysis: Effects of Different Depolarizing Stimuli

  1993cited by this paper
• The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5‐HT release in the frontal cortex of freely‐moving rats

  1993cited by this paper
• THE ANXIOGENIC EFFECTS OF CCK‐4 IN MONKEYS ARE REDUCED BY CCK‐B ANTAGONISTS' BENZODIAZEPINES OR ADENOSINE A2 AGONISTS

  1992cited by this paper
• Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures.

  1992cited by this paper
• In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: significant enhancement by immobilization stress in rats.

  1992cited by this paper
• GABA, acting at both GABAA and GABAB receptors, inhibits the release of cholecystokinin-like material from the rat spinal cord in vitro.

  1992cited by this paper
• Molecular analysis of an auxin binding protein gene located on chromosome 4 of Arabidopsis.

  1992cited by this paper
• Evaluation of the effects of PD 134308 (CI-988), a CCK-B antagonist, on the punished responding of squirrel monkeys.

  1991cited by this paper
• 'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.

  1991cited by this paper
• Involvement of the dorsal hippocampus in mediation of the antianxiety action of tandospirone, a 5-hydroxytryptamine1A agonistic anxiolytic.

  1991cited by this paper
• The behavioural properties of CI‐988, a selective cholecystokininB receptor antagonist

  1991cited by this paper
• Anxiolytic effects of CCK-B antagonists.

  1991cited by this paper
• Cholecystokinin-like immunoreactivity in the dorsal horn of the rat spinal cord: an attempt to analyse contradictory results between immunocytochemistry and radioimmunoassay.

  1990cited by this paper
• Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis.

  1989cited by this paper
• Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists

  1987cited by this paper
• Pharmacological study on the mixed CCK8/DA meso-nucleus accumbens pathway: evidence for the existence of storage sites containing the two transmitters.

  1984cited by this paper
• Reduction by two benzodiazepines and pentobarbitone of the multiunit activity in substantia nigra, hippocampus, nucleus locus coeruleus and nucleus raphé dorsalis of encéphale isolé rats.

  1983cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper

• Noradrenergic contributions to cue-driven risk-taking and impulsivity

  2021cites this paper
• Neurochemical underpinning of hemodynamic response to neuropsychiatric drugs: A meta- and cluster analysis of preclinical studies

  2020cites this paper
• Stress Impacts the Regulation Neuropeptides in the Rat Hippocampus and Prefrontal Cortex

  2018cites this paper
• Dissociable effects of systemic and orbitofrontal administration of adrenoceptor antagonists on yohimbine‐induced motor impulsivity

  2017cites this paper
• Peripheral α2-β1 adrenergic interactions mediate the ghrelin response to brain urocortin 1 in rats

  2014cites this paper
• Role of the Cholecystokinin System in Anxiolytic Activity of Dipeptide GB-115

  2012cites this paper
• Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders--the case of yohimbine.

  2010cites this paper
• Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.

  2009cites this paper
• CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies

  2006cites this paper
• Involvement of Cholecystokininergic Systems in Anxiety-Induced Hyperalgesia in Male Rats: Behavioral and Biochemical Studies

  2005cites this paper
• Facteurs de variabilité de l'effet de substances anxiolytiques sur le labyrinthe en croix surélevé chez la Souris

  2005cites this paper
• Phenoxybenzamine and Benextramine, but Not 4-Diphenylacetoxy-N-[2-chloroethyl]piperidine Hydrochloride, Display Irreversible Noncompetitive Antagonism at G Protein-Coupled Receptors

  2005cites this paper
• Psychosocial conditions and the efficacy of clinically available anxiolytics.

  2004cites this paper
• The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse.

  2004cites this paper
• Region-specific effects of acute and repeated restraint stress on the phosphorylation of mitogen-activated protein kinases.

  2003cites this paper
• The neurobiology and control of anxious states.

  2003cites this paper
• Neuroendocrine pharmacology of stress.

  2003cites this paper
• Enhanced Cortical Extracellular Levels of Cholecystokinin-Like Material in a Model of Anticipation of Social Defeat in the Rat

  2001influential citation
• Delayed stress-induced increase in tissue level of cholecystokinin in rat prefrontal cortex: modulation by microdialysis probe implantation and systemic ketamine.

  2001cites this paper
• The brain decade in debate: VIII. Peptide hormones and behavior: cholecystokinin and prolactin.

  2001cites this paper
• Interactive effects of cholecystokinin-8S and various serotonin receptor agonists on the firing activity of neostriatal neuronesin rats.

  2001cites this paper
• Agents in Development for Anxiety Disorders

  2000cites this paper
• δ-Opioid receptor-mediated increase in cortical extracellular levels of cholecystokinin-like material by subchronic morphine in rats

  2000cites this paper